Digital PCR Analytics For Cell And Gene Therapy Workflows

Achieving reliable, absolute quantification is essential for advancing cell and gene therapy programs from early discovery through QC and into commercialization. The QIAcuity® Digital PCR System enables teams to generate highly sensitive, reproducible results without relying on standard curves, helping reduce rework and strengthening confidence in critical measurements. With partitioning, thermocycling, and imaging combined in a single instrument, the workflow offers true walk-away automation and minimizes hands-on time. The streamlined, qPCR-like experience supports both exploratory studies and regulated QC environments, making it easier to scale throughput as development needs evolve. It also supports key applications, including vector copy number (VCN) determination, genome integrity analysis, residual impurity detection, mycoplasma testing and RCL quantification, all critical quality attributes (CQAs) that are essential for ensuring safety, identity, strength and purity of CGT products.

Access the full brochure to see how this approach helps teams simplify quantification, increase operational efficiency and support CGT programs at every stage